Griffin Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-408
Closed -$269K 232
2021
Q4
$269K Hold
408
0.03% 208
2021
Q3
$254K Hold
408
0.03% 216
2021
Q2
$258K Sell
408
-37
-8% -$20.4K 0.03% 221
2021
Q1
$218K Buy
445
+37
+9% +$18.5K 0.03% 224
2020
Q4
$204K Buy
+408
New +$183K 0.03% 215
2020
Q3
Sell
-726
Closed -$240K 211
2020
Q2
$240K Buy
+726
New +$210K 0.04% 183

Other funds holding IDXX

Griffin Asset Management's IDXX Position: Q1 2022 in Review

Griffin Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 408 shares — an estimated $269K sold.

Griffin Asset Management first reported a position in IDXX in Q2 2020 and held it in 6 quarters. The position peaked at $269K in Q4 2021. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

  • Griffin Asset Management reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
  • Griffin Asset Management sold 408 Idexx Laboratories shares in Q1 2022, an estimated $269K.
  • Griffin Asset Management first reported a position in Idexx Laboratories in Q2 2020 and held it in 6 quarters.
  • Griffin Asset Management's Idexx Laboratories position peaked at $269K in Q4 2021.
  • 1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Griffin Asset Management's 13F filing for Q1 2022, filed 12 Apr 2022.